deltatrials
Completed PHASE3 NCT00000120

Clinical Trial of Eye Prophylaxis in the Newborn

Sponsor: National Eye Institute (NEI)

Conditions Chlamydia Infections Ophthalmia Neonatorum
Interventions Erythromycin Ointment Silver Nitrate Drops
Updated 5 times since 2017 Last updated: Sep 16, 2009 Started: Jan 31, 1985

This PHASE3 trial investigates Chlamydia Infections and Ophthalmia Neonatorum and is currently completed. National Eye Institute (NEI) leads this study, which shows 5 recorded versions since 1985 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Jan 1985

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Eye Institute (NEI)
Data source: National Eye Institute (NEI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.